PTEN and hepatocellular carcinoma: The endocytosed AFP can interact with PTEN and activate the PI3K/AKT/mTOR pathway, which promotes the malignant behavior of hepatocellular carcinoma (HCC) cells by upregulating the protein expression of mTOR (13–17) (Figure 1).